Implanon: A new contraceptive implant

被引：19
|
作者：
Fischer, Mary A. [1 ,2 ]
机构：
[1] Univ Massachusetts, Grad Sch Nursing, Worcester, MA 01655 USA
[2] Harvard Vanguard Med Associates, Dept Obstet & Gynecol, Worcester, MA USA
来源：
JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING | 2008年 / 37卷 / 03期
关键词：
contraception; progestin-only contraception; contraceptive implants; etonogestrel;
D O I：
10.1111/j.1552-6909.2008.00247.x
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
Women who cannot use hormonal contraception containing estrogen have a variety of progestin-only contraceptive methods from which to choose. Implanon is a new single-rod progestin-only contraceptive implant that is easily inserted and can remain in place for up to 3 years. It is highly effective with a rapid onset of action and an equally rapid return of fertility once removed. Counseling is important to help women decide if this method is appropriate for their needs.
引用
收藏
页码：361 / 368
页数：8
相关论文
共 50 条
  • [1] Implanon: The Subdermal Contraceptive Implant
    Isley, Michelle
    JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2010, 23 (06) : 364 - 367
  • [2] Implanon: Subdermal single rod contraceptive implant
    Bhatia P.
    Nangia S.
    Aggarwal S.
    Tewari C.
    The Journal of Obstetrics and Gynecology of India, 2011, 61 (4) : 422 - 425
  • [3] Migration of implanon contraceptive implant into the pulmonary artery
    Cerato, A.
    Luyckx, M.
    Ghaye, B.
    DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2019, 100 (01) : 59 - 60
  • [4] Endometrial effects of etonogestrel (Implanon) contraceptive implant
    Varma, R
    Mascarenhas, L
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2001, 13 (03) : 335 - 341
  • [5] Effectiveness and safety of the new contraceptive one-rod implant Implanon®
    Tuyet, H. T. D.
    Trang, H. N. K.
    CONTRACEPTION, 2007, 76 (02) : 171 - 171
  • [6] Safety profile of etonogestrel contraceptive implant (Implanon® Nexplanon®)
    Simon, C.
    Vrignaud, L.
    Bene, J.
    Muller, C.
    Bejan-Angoulvant, T.
    Jonville-Bera, A. P.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2014, 28 : 112 - 112
  • [7] Safety and efficacy of the subdermal etonogestrel contraceptive implant Implanon®
    Beerthuizen, Rob
    JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2017, 43 (02): : 118 - 118
  • [8] Pharmacokinetics of etonogestrel released from the contraceptive implant Implanon®
    Wenzl, R
    van Beek, A
    Schnabel, P
    Huber, J
    CONTRACEPTION, 1998, 58 (05) : 283 - 288
  • [9] A multicentre efficacy and safety study of the single contraceptive implant Implanon®
    Croxatto, HB
    Urbancsek, J
    Massai, R
    Bennink, HC
    van Beek, A
    HUMAN REPRODUCTION, 1999, 14 (04) : 976 - 981
  • [10] SELECTION OF A CONTRACEPTIVE IMPLANT (IMPLANON) BY AN URBAN POPULATION IMMEDIATELY POSTPARTUM
    Nodler, J. L.
    Smith, H. J.
    Arbuckle, J. L.
    Chapman, V. C.
    Hoover, K. H.
    Biggio, J. R.
    FERTILITY AND STERILITY, 2011, 96 (03) : S111 - S111
12345